# Should Low Birth Weight Infants Be Vaccinated With BCG Vaccine at Birth in Developing Countries?

> **NCT00146302** · PHASE4 · COMPLETED · sponsor: **Bandim Health Project** · enrollment: 2320 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **BIOLOGICAL:** Bacille Calmette Guerin (BCG)

## Key facts

- **NCT ID:** NCT00146302
- **Lead sponsor:** Bandim Health Project
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 2320 (ACTUAL)
- **Last updated:** 2012-03-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00146302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00146302, "Should Low Birth Weight Infants Be Vaccinated With BCG Vaccine at Birth in Developing Countries?". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00146302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*